GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Insmed Inc (LTS:0JAV) » Definitions » Days Sales Outstanding

Insmed (LTS:0JAV) Days Sales Outstanding : 40.35 (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Insmed Days Sales Outstanding?

Insmed's average Accounts Receivable for the three months ended in Sep. 2024 was $41.3 Mil. Insmed's Revenue for the three months ended in Sep. 2024 was $93.4 Mil. Hence, Insmed's Days Sales Outstanding for the three months ended in Sep. 2024 was 40.35.

The historical rank and industry rank for Insmed's Days Sales Outstanding or its related term are showing as below:

LTS:0JAV' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.09   Med: 39.97   Max: 204.67
Current: 41.84

During the past 13 years, Insmed's highest Days Sales Outstanding was 204.67. The lowest was 33.09. And the median was 39.97.

LTS:0JAV's Days Sales Outstanding is ranked better than
76.24% of 867 companies
in the Biotechnology industry
Industry Median: 70.69 vs LTS:0JAV: 41.84

Insmed's Days Sales Outstanding increased from Sep. 2023 (38.39) to Sep. 2024 (40.35).


Insmed Days Sales Outstanding Historical Data

The historical data trend for Insmed's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insmed Days Sales Outstanding Chart

Insmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.09 39.73 39.62 40.21 42.40

Insmed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.39 41.85 47.35 39.12 40.35

Competitive Comparison of Insmed's Days Sales Outstanding

For the Biotechnology subindustry, Insmed's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Insmed's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Insmed's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Insmed's Days Sales Outstanding falls into.



Insmed Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Insmed's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (29.713 + 41.189) / 2 ) / 305.208*365
=35.451 / 305.208*365
=42.40

Insmed's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding (Q: Sep. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Sep. 2024 )) / count ) / Revenue (A: Sep. 2024 )*Days in Period
=( (40.3 + 42.317) / 2 ) / 93.425*365 / 4
=41.3085 / 93.425*365 / 4
=40.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Insmed  (LTS:0JAV) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Insmed Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Insmed's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Insmed Business Description

Traded in Other Exchanges
Address
700 US Highway 202/206, Bridgewater, NJ, USA, 08807
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.

Insmed Headlines

No Headlines